[Cryptococcus neoformans meningoencephalitis in a patient treated with rituximab].
Sánchez-Ojanguren
José
J
Isern-Segura
Irina
I
Chico-Chumillas
Cristina
C
Javaloyas-de-Morlius
Manuel
M
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D016919:Meningitis, Cryptococcal / Q000139:chemically induced*; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab